Long-term outcomes on quality-of-life and health care costs in patients with supraventricular tachycardia (radiofrequency catheter ablation versus medical therapy)
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In a 5-year study of patients with mild-to-moderate symptomatic supraventricular tachycardia, Goldberg et al. found that radiofrequency ablation compared with pharmacological treatment was associated with sustained improvement in quality of life and reduction in disease-specific symptoms, particularly in women and patients aged under 50 years.
“In a 5-year study performed in patients with mild-to-moderate symptomatic SVT, Goldberg et al. found that RF ablation when compared to pharmacological treatment was associated with a sustained improvement in QoL and a reduction in disease-specific symptoms, particularly in women and patients aged ,50 years.254”
From European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE) (2017) · cites this paper as [254]
Every study has demonstrated an improvement in self-reported quality of life following ablation.
“Every study has demonstrated an improvement in self-reported QoL following ablation.2,245,246,254 -256,258,424,425”
From European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE) (2017) · cites this paper as [254]
Almost all studies examining quality of life with validated questionnaires have been conducted in patients undergoing catheter ablation for supraventricular tachycardia, often without a comparison group.
“Almost all of the studies examining QoL, measured with validated questionnaires, have been conducted in patients undergoing catheter ablation for SVT, 245,246,254 - 256,258,424,425 although often without a comparison group.”
From European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE) (2017) · cites this paper as [254]
Several studies have investigated patient-reported quality of life and may offer some insight into patient preferences where particular therapies result in improvements in quality of life.
“Several studies have investigated patient-reported QoL, 2,245,246,254 -256,258,424,425 and these may offer some insight into patient preferences for treatment where particular therapies result in improvements in QoL.”
From European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE) (2017) · cites this paper as [254]
The citation lists haven’t been fetched yet
References 11 · Cited by 67
- Authors
- Goldberg, A. S., Bathina, M. N., Mickelsen, S., Nawman, R., West, G., & Kusumoto, F. M.
- Affiliations
- Lovelace Medical Center (US)
- University of New Mexico (US)
- Corresponding author
- Kusumoto, Fred M.
- Venue
- The American Journal of Cardiology
- Publisher
- Elsevier BV
- Published
- 2002-05
- Volume
- 89
- Issue
- 9
- Pages
- 1120-1123
- ISSN
- 0002-9149 (ISSN-L)
- OpenAlex
- W2132313874
- Cited by
- 67
- References
- 11
- Citations by year
- 2026: 3 · 2024: 6 · 2023: 2 · 2022: 2 · 2021: 5 · 2020: 5 · 2019: 1 · 2018: 3 · 2017: 2 · 2016: 4 · 2015: 6 · 2014: 4 · 2013: 4 · 2012: 4
- FWCI
- 0.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The American Journal of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Keywords
- supraventricular tachycardia, radiofrequency catheter ablation, medical therapy, quality of life, health care costs, cost-effectiveness, long-term outcomes, atrioventricular nodal reentrant tachycardia, Wolff-Parkinson-White syndrome, drug-refractory arrhythmia, activities of daily living
- MeSH terms
- Age Factors, Anti-Arrhythmia Agents, Female, Humans, Male, Middle Aged, Prospective Studies, Quality of Life, Sex Factors, Tachycardia, Supraventricular, Time, Health Care Costs, Outcome Assessment, Health Care, Catheter Ablation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
